Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I0MT
|
|||
| Drug Name |
Aryl carboxamide derivative 4
|
|||
| Synonyms |
PMID25539043-Compound-WO2011103196Example36
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
AMGEN INC. BREGMAN, Howard BUCHANAN, John, L. CHAKKA, Nagasree DIMAURO, Erin, F. DU, Bingfan NGUYEN, Hanh, Nho ZHENG, Xiao, Mei
|
|||
| Structure |
 |
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated sodium channel alpha Nav1.7 (SCN9A) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Voltage-gated sodium channel alpha Nav1.7 (SCN9A) | Target's Patent Info | [1] | |
| Reactome | Interaction between L1 and Ankyrins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Sodium channel blockers: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015 Mar;25(3):279-90. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.